[待更新] Advancing Antibody-Drug Conjugates for Cancer
Seattle Genetics is a biotechnology company focused on developing and commercializing innovative, empowered antibody-based therapies for the treatment of cancer. We are the industry leader in antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells.w recruiting View all clinical trials Highlights Third Quarter 2013 Financial Results November 5, 2...
